Compared to daily oral pre‐exposure prophylaxis (PrEP), lenacapavir reduces the number of new HIV infections by many more; causes slightly fewer serious unwanted effects; and, results in little to no difference in overall unwanted effects or risk of death. Lenacapavir likely causes more mild to moderate injection site reactions than oral PrEP.

The South African Medical Research Council (SAMRC) recently hosted Professor Tulio de Oliveira, Director of the Centre for Epidemic Response and Innovation (CERI) at Stellenbosch University, for a President and CEO Lecture titled "Accelerating genomics-based surveillance for disease-causing pathogens in Africa."

South Africa is facing a growing diabetes crisis that demands urgent, coordinated action from government, researchers, healthcare providers, civil society and communities, according to Dr Patrick Ngassa Piotie, Chairperson of the Diabetes Alliance and Co-founder of the University of Pretoria Diabetes Research Centre, during a recent South African Medical Research Council (SAMRC) President and CEO Lecture.

Innovation in sport today extends far beyond the stadium, field, or training ground. Increasingly, it is shaped by the convergence of health research, intellectual property (IP), data governance, wearable technologies, artificial intelligence, and technology transfer.

Cochrane South Africa (CSA) is excited to announce becoming an Institutional Member of the World Health Organization’s (WHO) Health Inequality Monitoring (HIM) Network as of 7 May 2026. Led by Specialist Scientist Dr Anelisa Jaca, CSA joins the WHO-managed Network that brings together institutions committed to advancing health inequality monitoring globally and strengthening the use of equity-focused evidence to inform policy and decision-making.